| Name | Title | Contact Details |
|---|
URAC is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Valley Medical Center (VMC), also known as King County Public Hospital District No. 1, is located in Renton, WA. The Medical Center’s service area includes the communities of Renton, Kent, Tukwila, Covington, Maple Valley, Auburn, Newcastle and the surrounding environs. A 303-bed acute care hospital and clinic network, VMC is committed to providing safe, quality compassionate care and has done so for more than 63 years. Seattle magazine named VMC the #1 non-profit in the state for 2011, the Puget Sound Business Journal honored VMC as “Washington’s Best Workplace” for 2011 in the extra large company category, and for ten consecutive years VMC has been named a “Best Workplace” by regional publications. For the past four out of four years VMC has been named a “Best Place to Work in Healthcare” in the nation by Modern Healthcare magazine, including twice achieving a top 10 ranking. Valley Medical Center is a component entity of UW Medicine.
Visiting Angels Living Assistance Services is a Stockton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CRB Engineers, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Kansas City, MO. To find more information about CRB Engineers, Inc., please visit www.crbusa.com
Kite Pharma, founded in 2009, is dedicated to the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to fight tumor cells. Kite’s lead programs are in collaboration with the National Cancer Institute (NCI) and are being studied through the NCI’s Surgery Branch led by Steven A. Rosenberg, MD, PhD, who has pioneered immunotherapy approaches for cancer for more than two decades. This research has resulted in breakthrough clinical findings, including results from an NCI Phase 1/2a trial being presented at this year’s American Society of Hematology (ASH) Annual Meeting. Based on this progress and momentum, Kite plans to initiate a company-sponsored multicenter clinical program in aggressive non-Hodgkin’s lymphoma, with additional filings expected for other eACT™ products in diverse oncology indications.